BRPI0603762A - uso de agomelatina para obtenção de medicamentos intencionados para o tratamento de distúrbios de sono em pacientes deprimidos - Google Patents

uso de agomelatina para obtenção de medicamentos intencionados para o tratamento de distúrbios de sono em pacientes deprimidos

Info

Publication number
BRPI0603762A
BRPI0603762A BRPI0603762-3A BRPI0603762A BRPI0603762A BR PI0603762 A BRPI0603762 A BR PI0603762A BR PI0603762 A BRPI0603762 A BR PI0603762A BR PI0603762 A BRPI0603762 A BR PI0603762A
Authority
BR
Brazil
Prior art keywords
treatment
sleep disorders
agomelatine
depressed patients
drugs intended
Prior art date
Application number
BRPI0603762-3A
Other languages
English (en)
Inventor
Bruno Delalleau
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36200255&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0603762(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of BRPI0603762A publication Critical patent/BRPI0603762A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

USO DE AGOMELATINA PARA OBTENçãO DE MEDICAMENTOS INTENCIONADOS PARA O TRATAMENTO DE DISTúRBIOS DE SONO EM PACIENTES DEPRIMIDOS.A presente invenção refere-se ao uso de agomelatina, ou N-{2-(7-metóxi-1-naftil)etil}acetamida, na obtenção de medicamentos intencionados para o tratamento de distúrbios de sono em pacientes deprimidos.
BRPI0603762-3A 2005-09-09 2006-09-06 uso de agomelatina para obtenção de medicamentos intencionados para o tratamento de distúrbios de sono em pacientes deprimidos BRPI0603762A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509207A FR2890562B1 (fr) 2005-09-09 2005-09-09 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime

Publications (1)

Publication Number Publication Date
BRPI0603762A true BRPI0603762A (pt) 2007-05-15

Family

ID=36200255

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0603762-3A BRPI0603762A (pt) 2005-09-09 2006-09-06 uso de agomelatina para obtenção de medicamentos intencionados para o tratamento de distúrbios de sono em pacientes deprimidos

Country Status (26)

Country Link
US (1) US20070060655A1 (pt)
EP (2) EP1762237A1 (pt)
JP (1) JP2007077148A (pt)
KR (2) KR20070029608A (pt)
CN (1) CN1927193B (pt)
AP (1) AP2008004379A0 (pt)
AR (1) AR056063A1 (pt)
AU (1) AU2006209372A1 (pt)
BR (1) BRPI0603762A (pt)
CA (1) CA2558762A1 (pt)
EA (1) EA014288B1 (pt)
FR (1) FR2890562B1 (pt)
GE (1) GEP20094602B (pt)
GT (1) GT200600409A (pt)
HK (1) HK1100481A1 (pt)
MA (1) MA28506B1 (pt)
MX (1) MXPA06010233A (pt)
NO (1) NO20064050L (pt)
NZ (1) NZ549726A (pt)
PE (1) PE20070333A1 (pt)
SG (1) SG146451A1 (pt)
TW (1) TW200800148A (pt)
UA (1) UA81573C2 (pt)
UY (1) UY29777A1 (pt)
WO (1) WO2007028905A1 (pt)
ZA (1) ZA200607531B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918370B1 (fr) * 2007-07-02 2009-08-28 Servier Lab Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2918372B1 (fr) * 2007-07-02 2009-08-28 Servier Lab Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
CN101991559B (zh) * 2010-11-25 2012-04-18 天津市汉康医药生物技术有限公司 一种稳定的阿戈美拉汀胶囊药物组合物
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
WO2013119605A1 (en) * 2012-02-07 2013-08-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Promoting sleep using at1 receptor blockers
CN102552211B (zh) * 2012-02-16 2013-07-17 福建广生堂药业股份有限公司 一种阿戈美拉汀的制剂组合物及其制备方法
PT2810656T (pt) 2013-06-06 2017-11-13 Zentiva As Formulações de agomelatina compreendendo agomelatina na forma de cocristais
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
EP2856934A1 (en) * 2013-10-04 2015-04-08 Les Laboratoires Servier Biomarkers for the prediction of long term remission in depression
CN103690499B (zh) * 2013-12-23 2015-05-06 天津泰普药品科技发展有限公司 一种稳定的晶i型阿戈美拉汀片剂及其制备方法
CN103655499B (zh) * 2013-12-23 2015-07-22 天津泰普药品科技发展有限公司 一种稳定的晶x型阿戈美拉汀片剂及其制备方法
CN104523639B (zh) * 2014-12-11 2017-03-22 扬子江药业集团四川海蓉药业有限公司 一种阿戈美拉汀片剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
JP2007517040A (ja) * 2003-12-24 2007-06-28 セプレイコー インコーポレイテッド 睡眠の質を改善するためのメラトニン併用療法
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
US7645905B2 (en) * 2005-08-03 2010-01-12 Les Laboratoires Servier Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7635721B2 (en) * 2005-08-03 2009-12-22 Les Laboratoires Servier Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
FR2890562A1 (fr) 2007-03-16
KR20070029608A (ko) 2007-03-14
NZ549726A (en) 2008-03-28
SG146451A1 (en) 2008-10-30
KR20080103043A (ko) 2008-11-26
EP2295050A1 (fr) 2011-03-16
GEP20094602B (en) 2009-02-10
GT200600409A (es) 2007-04-30
WO2007028905A1 (fr) 2007-03-15
AU2006209372A1 (en) 2007-03-29
JP2007077148A (ja) 2007-03-29
FR2890562B1 (fr) 2012-10-12
NO20064050L (no) 2007-03-12
EA014288B1 (ru) 2010-10-29
UA81573C2 (en) 2008-01-10
PE20070333A1 (es) 2007-06-02
CN1927193A (zh) 2007-03-14
MA28506B1 (fr) 2007-04-03
TW200800148A (en) 2008-01-01
HK1100481A1 (en) 2007-09-21
CA2558762A1 (fr) 2007-03-09
AP2008004379A0 (en) 2008-04-30
CN1927193B (zh) 2011-01-05
AR056063A1 (es) 2007-09-19
EA200601449A1 (ru) 2007-04-27
UY29777A1 (es) 2006-10-31
MXPA06010233A (es) 2007-03-08
EP1762237A1 (fr) 2007-03-14
US20070060655A1 (en) 2007-03-15
ZA200607531B (en) 2008-05-28

Similar Documents

Publication Publication Date Title
BRPI0603762A (pt) uso de agomelatina para obtenção de medicamentos intencionados para o tratamento de distúrbios de sono em pacientes deprimidos
BRPI0701601A (pt) uso de agomelatina na obtenção de medicamentos previstos para o tratamento do dirtúrbio de ansiedade generalizada
BRPI0601285A (pt) uso de agomelatina na obtenção de medicamentos destinados ao tratamento de distúrbios bipolares
EA200702318A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения синдрома смита-магениса
BRPI0704179A (pt) uso de agomelatina na obtenção de medicamentos pretendidos para o tratamento de leucomalacia periventricular
EA201201123A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения обсессивно-компульсивного расстройства (окр)
CU20070232A7 (es) Utilización de la agomelatina para la obtención de medicamentos destinados al tratamiento de los trastornos bipolares
CU20070070A7 (es) Composición farmacéutica de agomelatina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2270 DE 08/07/2014.